Global Research Push Resonates Across Airwaves
News of the newly launched Global Ovarian Cancer Research Consortium — and its inaugural AI Accelerator Grant — is spreading quickly, with media outlets across the country taking notice. The … Continued
OCRA Board of Directors
Our Board
Distinguished leaders from fields including healthcare, law, entertainment, hospitality, and more make up our Board of Directors. While diverse in their areas of expertise, all of our members are united in their passion to advance ovarian and related gynecologic cancer research, help guide our path forward, and contribute toward our goal of finding a cure.
Board Members
Debra Birnbaum
Jeannette Chang
Carmel J. Cohen, MD
Emeritus Executive Committee Member
Mei-Li da Silva Vint, Esq.
Andrew Feuerstein, Esq.
Carol J. Hamilton
John W. Hansbury, Esq.
Emeritus Executive Committee Member
Caroline Hirsch
Veronica Jordan, PhD
Dana L. Mark, Esq.
Emeritus Executive Committee Member
Chris Newcomb
Melissa Rivkin
Lisa Schreiber
Elle Simone Scott
Laura Shawver, PhD
Chris Tilberis
Related Topics
New Global Ovarian Cancer Research Consortium Joins Forces with Microsoft’s AI for Good Lab to Launch First-Of-Its-Kind $1M Global Grant to Improve Survival Rates
Four leading ovarian cancer research charities from four countries are funding a new AI Accelerator Grant in partnership with Microsoft’s AI for Good Lab to supercharge the next cancer research … Continued
OCRA’s Health Equity Research Grant Recipients
In the newest installment of our continuing introduction of our 2025 grantees, Ovarian Cancer Research Alliance (OCRA) is proud to highlight the three recipients of our 2025 Health Equity Research Grants, … Continued